AzTrials
AzTrials

Upper Cross SyndromeNCT07017738

Effect of Neural Mobilization in Upper Cross Syndrome

A study testing Corrective exercises and Neural mobilization in people with Upper Cross Syndrome, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of Neural Mobilization in patients with Upper Cross Syndrome. Read more about this study

Who is it for?
Ages 20 to 50 years
Conditions the study is for
Upper Cross Syndrome
What is being tested?
Corrective exercises and Neural mobilization
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
10 Jun 2025to 15 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age ranged from 20 to 50 years.
  • Body Mass Index ≤30 kg/m².
  • All participants have a forward head, craniovertebral angle < 50°.
  • All participants have round back (kyphosis angle ≥ 42°).
  • All participants have rounded shoulders of ≥ 52°.
  • The subjects were chosen from both genders based on an assessment of upper cross syndrome by photogrammetric analysis.
  • All participants have pain intensity level measured by visual analogue scale (4-8).
  • All participants tested positive for upper limb tension test of median nerve.

Who cannot join

  • History of trauma or surgery in the cervical region.
  • Bone fractures or acute soft tissue injuries.
  • Osteoporosis.
  • Pregnant women.
  • Cancer.
  • Neurological conditions affecting cervical and thoracic spine.
  • Connective tissue disease: This includes diseases such as osteomyelitis, lupus, and scleroderma.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo University

    Giza

Other trials in Egypt

About this study

The purpose of this study is to investigate the effect of Neural Mobilization in patients with Upper Cross Syndrome.

Read the detailed description

Upper cross syndrome (UCS) is the tightness of the levator scapulae, pectoralis major, and upper trapezius whereas inhibition of serratus anterior, deep neck flexors more specifically scalene, middle trapezius, lower trapezius, and rhomboids. This condition is given its name because a cross can be drawn across the upper body. One arm of the cross indicates the tight muscles and the other arm of the cross indicates the inhibited muscles.

People suffering from UCS present with a forward head posture (FHP), hunching of the thoracic spine (rounded upper back), elevated and protracted shoulders, scapular winging, and decreased mobility of the thoracic spine. Sometimes, manual work can cause musculoskeletal disorders, for example, the workers who do their work in awkward positions repeat the same action throughout their workday.

It was found that UCS causes pain among 24.3% of drivers. Also, 35.9% of office workers suffer from the upper cross syndrome and body posture was the leading cause. Housewives were also suffering from upper cross syndrome. The reason behind this is that during household tasks they don't keep a good posture which causes them pain and other difficulties.

Patients complaining of non-traumatic neck pain tend to keep the forward head posture, when compared to people without pain.

Rounded shoulder has been identified as a leading cause of upper quarter pain. Kyphosis, by both clinical and quantitative assessment, causes diminished function especially in tasks that require mobility.

The effect of neural mobilization in various diseases and conditions includes increasing nerve conduction and functional status, decreasing pain and subjective symptoms.

Accordingly, there are no available studies in the literature investigating the effect of neural mobilization on the upper cross syndrome, therefore this is the purpose of the study.

Being tested
Corrective exercises, Neural mobilization
Medical subject headings
Oculocerebral hypopigmentation syndrome type Preus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Corrective exercisesOther

    The corrective exercise program will include various positions: in standing, scapular retraction and arms overhead; in sitting, chin tuck and thoracic extension; in supine, arms in a W shape and horizontal abduction with external rotation; in side-lying, forward flexion starting with arms parallel to the body; and in prone, scapular retraction and depression in a T shape, extension from 90° forward flexion, and horizontal abduction at 90° with external rotation. Exercises will start with three repetitions held for 10 seconds and progress to six repetitions held for 25 seconds, based on overload principles and individual needs. Participants experiencing pain may stop and rest until symptoms subside.

  • Neural mobilizationOther

    Median nerve mobilization will be performed with the patient in a supine position, shoulder abducted to 90°, elbow flexed at 90°, and both wrist and head in a neutral position. The therapist will mobilize the nerve by extending the elbow to 45°, while the patient performs ipsilateral cervical lateral flexion to unload the nervous system.

Study groups in NCT07017738
Study groupRoleWhat they receive
Neural mobilization + Corrective exercisesExperimentalThey will receive neural mobilization in addition to corrective exercises for UCS, 3 times per week for 6 weeks.
Receives: Other: Corrective exercises; Other: Neural mobilization
Corrective exercisesActive comparatorThey will receive corrective exercise for UCS, 3 times per week for 6 weeks.
Receives: Other: Corrective exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Forward head angle

    The forward head angle between the line connecting the tragus and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Measured: 6 weeks

  2. Rounded shoulder angle

    The rounded shoulder angle between the line between the acromion process and C7 with the perpendicular line will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Measured: 6 weeks

  3. Kyphosis angle

    For the kyphosis angle, the bone marker on the spinous process of C7 will be used as the starting point of the arch and the spinous process of T12 will be used as the endpoint of the arch. It will be measured for all participants in both groups pre- and post-treatment, using the photogrammetric method.

    Measured: 6 weeks

Secondary outcomes (1)
  1. Boston Questionnaire (Arabic version)

    The Boston Questionnaire is a patient-reported outcome measure that has demonstrated reliability, validity, and responsiveness to both surgical and non-surgical treatments. The Arabic version has also been shown to be reliable and valid among Arabic-speaking patients. The questionnaire consists of two separate scales: the Symptom Severity Scale (SSS), which includes 11 questions, and the Functional Status Scale (FSS), which includes 8 items. Respondents rate the difficulty of each item using a five-point scale. Higher scores indicate greater symptom severity or functional impairment.

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2025
  2. Study start10 Jun 2025
  3. Primary completion10 Dec 2025
  4. Study completion15 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07017738
Sponsor's protocol ID
P.T.REC/012/005577
Status last verified
Jan 2026
First submitted
4 Jun 2025
Last updated
9 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Corrective exercises and Neural mobilization in people with Upper Cross Syndrome, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Forward head angle (time frame: 6 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in